Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

CHESS Health Receives $1.5 Million Grant to Enhance eIntervention with more SBIRT Functionality
  • USA - English

Smartphone App Aimed at Prevention of Substance Use Disorder


News provided by

CHESS Health

Mar 03, 2020, 11:00 ET

Share this article

Share toX

Share this article

Share toX

ROCHESTER, N.Y., March 3, 2020 /PRNewswire-PRWeb/ -- CHESS Health, the leading provider of comprehensive addiction management technology, has received a fast-track grant of $1.5 million from the National Institute on Drug Abuse (NIDA). The goal of the grant, identified as 1R44DA050214, is to improve the rate at which those at risk of substance use disorder (SUD), or who require SUD treatment, actually follow through on recommendations following screening in a primary care setting.

CHESS Health's innovative eIntervention solution, launched in 2019, is currently deployed at dozens of medical and addiction providers nationwide, ranging from hospitals to MAT clinics to full-continuum behavioral health providers. The web-based solution automates referrals for treatment and wrap-around services through closed-loop provider-to-provider communications. In addition, eIntervention uniquely engages the patient throughout the transition of care through its companion Envoy app, which offers the patient real-time referral details, informative and motivating video content, and secure messaging with their providers.

The NIDA grant will fund the enhancement of the Envoy app to deliver targeted interventions to individuals reporting risky use of substances, but who have not yet developed full-onset SUD requiring treatment. Kathleen Carroll, PhD, the Albert E Kent Professor of Psychiatry at Yale University School of Medicine, will lead a panel of SBIRT experts in designing the preventative interventions to be added to the Envoy app. SBIRT is the clinical practice of screening for substance use, brief intervention and referral to treatment.

In order to streamline the administrative process, the grant is presented in two phases. For both phases, CHESS Health will collaborate with Cherry Health, the largest Federally Qualified Health Center in Michigan. In Phase 1, Cherry Health will conduct a usability trial of the Envoy app for patients referred to treatment for substance use disorder. In Phase 2, Cherry Health will conduct a randomized clinical trial of the effectiveness of the Envoy app in increasing successful referrals to treatment and in reducing substance use among those reporting risky use but not requiring treatment.

"This NIDA grant will enable us to add prevention functionality to our current addiction treatment technology platform, which already includes smartphone-delivered evidence-based treatment and recovery support, digital cognitive behavioral therapy (CBT), and referral to treatment," says Hans Morefield, chief executive officer of CHESS Health. "At CHESS, addressing the personal and societal crisis of addiction is foremost on our minds – preventing addiction is the next frontier."

Cherry Health's interest in the proposal was spurred by its commitment to fully integrate health services with substance use disorders and mental illness into its primary care mission as a Federally Qualified Health Center (FQHC).

"SBIRT is a terrific practice, but it is not enough when it comes to improving patient adherence to treatment referrals," says Leslie Pelkey, MD, and chief medical officer of Cherry Health. "That's why we're very interested in this initiative to improve health outcomes, and the overall patient experience by making SBIRT actionable."

"We have two goals with this grant," explained Dr. Carroll. "We want to double the current rate of follow-up specialty SUD care from approximately 17 percent to an achieved rate of at least 35 percent, and we want to measure a reduction in substance use among all patients that get the Envoy app. If we achieve these goals, this effort will be an important milestone in applying technology to the prevention of addiction."

About CHESS Health
CHESS Health creates innovative solutions designed at the intersection of science, technology and recovery. Founded by nationally recognized substance abuse researcher Dr. Dave Gustafson, CHESS developed A-CHESS, the leading evidence-based relapse prevention technology. By integrating A-CHESS into treatment plans, providers can best support those in recovery with access to predictive relapse analytics, condition-specific content and access to live support, which reduces relapse by 50% while decreasing costs and saving lives. The recent addition of eReferral capability prior to treatment, and an eTherapy functionality during treatment, creates an industry-leading technology platform to support the full continuum of care. CHESS Health has received recognition from the Substance Abuse and Mental Health Services Administration's National Registry of Evidence-based Programs and Practices (NREPP), the Journal of Substance Abuse, and the Surgeon General. For more information, visit http://www.chess.health.

About Cherry Health
Cherry Health is an independent, non-profit Federally Qualified Health Center (FQHC) with a primary focus of providing high quality health services to those who have little or no access to health care, regardless of income or insurance status. Services provided by Cherry Health include primary care, women's health, pediatrics, dental, vision, behavioral health, mental health, correctional health, five school-based health centers and employee assistance for employers. Cherry Health provides services to all individuals, with a slide fee scale based on income and family size is available to those with or without insurance. Medicaid and Healthy Michigan are accepted, as are many other insurances.

Established in 1988, Cherry Health is the largest FQHC in the State of Michigan serving Barry, Eaton, Kent, Montcalm, Muskegon, Ottawa and Wayne counties. Providing integrated health care services at more than 20 locations throughout Michigan, Cherry Health has approximately 900 employees and a network of over 60 physicians and mid-level providers specializing in primary care/family medicine, pediatrics, internal medicine, obstetrics/gynecology, optometry, oral health, behavioral health and substance use disorders. Additionally, Cherry Health runs a school linked program active in 70 public schools offering both vision and dental care. Cherry Health hosts about 66,000 annual health check-up visits per year, of which about 37,000 are patients 18 and over. For more information, visit cherryhealth.org.

SOURCE CHESS Health

Related Links

https://www.chess.health/

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.